CropLogic Commences Shipments Under Deschutes Labs Supply Agreement

  • Oct 30, 2019 AEDT
  • Team Kalkine
CropLogic Commences Shipments Under Deschutes Labs Supply Agreement

Perth-based award-winning global agronomy, agtech and farm management company, CropLogic Limited (ASX: CLI) specialises in soil moisture management solutions. The company, with over 100 years of combined experience across Australia and the USA, aims to help growers optimise crop profitability by providing simple, actionable in-field information.

The company has been making waves in the ASX pot stock space through its strategic move into Hemp CBD.

Industrial Hemp Supply Agreement

Confirming that its agronomy, farm management and agtech expertise can be successfully applied to industrial hemp and has been recognised by industry participants, CLI executed a Supply Agreement in August 2019 with Deschutes Labs , a new industrial hemp processing facility located in Central Oregon, USA.

As per the Agreement, Logical Cropping LLC, CLI’s wholly owned subsidiary would deliver Biomass on a weekly allotment basis from 20 October 2019. With payments to follow each delivery, the total Supply Agreement value is reportedly $15.4 million (provided the completion of deliveries).

Logical Cropping LLC Commences Biomass Shipment

On 28 October 2019, the Company announced that shipments have begun under the Deschutes Labs supply agreement.

With the harvest timeline on track, the Company made its first Biomass Shipment under the Agreement to Deschutes Labs, which aims to offer its customers with consistent and abundant CBD products through its relationship with CropLogic. In September 2019, the Lab began operations and is licensed to manufacture food grade extracts. Further, it is operated and designed in accordance with ISO 9000 and GMP standards.

CLI notified that even though there is an element of ‘dialling in’ of machinery and processes to the extent that would be commonly expected for a project such as the trial farm, the harvest is reportedly progressing well:

  • The methodology of swathing/ windrowing, field drying and combining biomass has been successful to date;
  • a process of brushing after combining had been considered;
  • management and buyers have been pleased with the consistency of biomass material from the combine, eliminating/reducing the need for brushing, consequently reducing the cost of brushing and streamlining the harvesting process.

Moreover, CLI’s warehousing procedure, which includes bagging the biomass into supersacks (Bulka Bags) weighing, tagging and storing for sale, is now being implemented.

The Course Of Events

  • On 9 August 2019, the Company negotiated the terms for a pre-revenue bridging finance loan of US$2 million with its existing lender, Atlas Capital Markets and subsequently received the loan amount (with Pre-Revenue Hemp Trial Farm Bridging Loan conditions precedent satisfied) to use the funds towards processing and the sale of product.
  • Commencing the review of Australian Industrial Hemp Trial Farm later in August, the Company signed a Letter of Intent with Boring Seed Company of Oregon USA to distribute hemp genetics into Australia and New Zealand.
  • On 13 September 2019, the Company announced that the Hemp Trial Farm had entered the fourth stage of development as the plants have begun to flower, a significant milestone as it is in the flowers that the CBD producing oils are predominantly found.
  • Advancing the Hemp Trial Farm activities, a third party, ORELAP performed Industrial Hemp compliance testing and confirmed that all fields under the Hemp Trial Farm have a THC level lower than the highest requirement for them to be considered industrial hemp. This demonstrated the robust growing methods and good genetics that were sourced through hemp expertise resourced by LogicalCropping.
  • On 21 October 2019, CLI reported that the harvests were progressing well and according to schedule, and trimmed flower hand cutting was complete.

Share Price Information

CLI quoted $0.047 on ASX after the trade session on 30 October 2019, with a market capitalisation of $20 million and approximately 416.61 million shares outstanding. The stock has generated a return of 23.08% in the past six months and has an impressive YTD return of 269.23% (as on 29 October 2019).

Hemp industry and the cannabis space has been gaining a lot of traction since the past few months in Australia, especially after the recent ease on recreational cannabis in the ACT, which followed the historic legalisation of medicinal cannabis in February 2016.


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. The above article is sponsored but NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) under discussion. We are neither licensed nor qualified to provide investment advice through this platform.


All pictures are copyright to their respective owner(s) does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


Penny stocks have been known to attract investors who are looking for explosive gains and it is possible to get lucky with these typically speculative investments. Just as the name suggests, penny stocks trade at low prices and are common shares of small public companies.

Get an exclusive insight into the features of penny stocks along with their pros and cons. Read about what you should be wary about when figuring out ways to invest in them, so that the possibility for big rewards does not tend to outweigh the risks.

Find out more about penny stock winners from 2019

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK